101 Therapeutics is a clinical stage pharma company curing infectious diseases by targeting the pathology not the the pathogen.
101 Therapeutics was founded in 2020 by Alec Goldberg, James Goldberg.
1282 health care and life sciences companies are in the directory, 186 of them in the same 1-10 employee range and 131 based in Europe.
“101 Therapeutics discovers and develops effective, easy-to-use, and well-tolerated therapies across oncology, autoimmune, metabolic, and rare diseases.” 101therapeutics.com
101 Therapeutics is a biopharma company based in Europe, with 1-10 employees, founded in 2020. It has raised $15 million over 2 rounds and its founders are Alec Goldberg and James Goldberg.
1-10 employees · abbiosciences.com
1-10 employees · abeomics.com
501-1,000 employees · apcerls.com
101-250 employees · aveooncology.com
11-50 employees · alxoncology.com
11-50 employees · acernatec.com
501-1,000 employees · abzena.com
1-10 employees · aeonbiopharma.com
501-1,000 employees · adaptimmune.com
51-100 employees · acimmune.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.